Next Quarterly Earnings
Wednesday, July 29, 2026
CW 31
After-Hours
In 24 days
Viking Therapeutics
Viking Therapeutics is a U.S.-based biopharmaceutical company specializing in the development of innovative, clinical therapeutics. The company is focused on novel drug candidates for metabolic and endocrine diseases, including obesity, NASH, and type 2 diabetes, with the goal of improving patient health and outcomes.
All Dates
Earnings history data not available
Company Information
Name
Viking Therapeutics
Country
🇺🇸
More Financial Information